FOLH1 and neoplasm: While targeted imaging provides an opportunity for whole-body phenotyping of PSMA expression at the macroscopic level, liquid biopsy testing, specifically of circulating tumor cells (CTCs), could offer an alternative method of PC disease identification and characterization (65).